Investor Packy McCormick: Neko New York Clinic $499 Experience Meets Standards
Investor Packy McCormick stated that he was the fourth person to preview Neko Health's new location in New York. The experience was complete from entering the door to going downstairs, with multiple scans, blood tests, and blood pressure checks completed in about 30 minutes. An on-site laboratory provided immediate results interpretation. He noted the price of $499 and that the company plans to include more tests at the same price point. The preview was free, but he has already paid for an appointment 12 months later and gave a full recommendation.
Neko was founded by Spotify Chairman Daniel Ek and Hjalmar Nilsonne. The official pricing and duration are $499 for about 60 minutes, non-invasive and radiation-free, covering millions of data points related to heart, blood, skin, and metabolism, with results provided during the visit and interpreted by clinical staff. The first store in New York is set to open on September 24 at 300 Lafayette Street in SoHo, spanning two floors and approximately 11,000 square feet with seven scanning rooms. The waiting list has reportedly exceeded 25,000 people. Future plans include more locations in New York, Miami, Washington, and San Francisco.
The company completed a $700 million Series C round before going public in the U.S. There are already stores in Sweden and the UK, with global registration and scanning volumes expected to rise significantly by 2025. The business model focuses on preventive packages to combat fragmented health checks and more expensive membership medical services, claiming to include follow-ups for cardiovascular and dermatological assessments within the fees. McCormick's 30-minute experience differs from the official 60 minutes, possibly indicating a shortened preview process that should not be considered the standard duration post-opening.
The $499 price is lower than common high-end health checks but higher than a typical co-pay for a regular check-up. The on-site laboratory is key to reducing turnaround time from several days to the same visit, and it is also a capital expenditure that can be replicated in other stores. He has prepaid for the following year, indicating that the product is being treated as a subscription rather than a one-time curiosity.
In market mechanics, this represents retail preventive healthcare. The buyer is the urban middle class willing to pay $499 for data before becoming ill; the seller is a tech clinic selling annual check-up packages using scanning rooms and its own laboratory. Funding flows from out-of-pocket payments into store capacity. Beneficiaries include early users who have queued and Neko, which needs to validate its customer price in the U.S.; those under pressure include imaging centers that charge per project and higher membership medical services. The event is driven by the preview experience post, with the official opening still two weeks away.
On a supplementary level, the $700 million funding is for expansion, not for the cost of a single scan. Details of blood transport have not been publicly disclosed.
Source: Public Information
ABAB AI Insight
To succeed in preventive healthcare, it is essential to sell a complete afternoon experience of "not feeling unwell yet." Neko transforms health checks from hospital processes into retail appointments with a designed basement, immediate results, and a price of $499. McCormick's post serves as a trust transfer before opening: the fourth previewer has paid for next year's service, and those on the waiting list will turn their experiences into a purchasable future. The official 60 minutes condensed to 30 minutes for him indicates that the preview does not equate to stable operational capacity.
The capital path is "Series C - flagship store - $499 annual check-up." The $700 million is aimed at expanding into Miami and San Francisco, and each store must prove the utilization of scanning rooms. Money flows from financing into renovations and laboratories, then back from out-of-pocket packages. The motivation is to sell a complete picture in the gap where U.S. insurance does not cover, competing with membership medical services costing thousands of dollars. The on-site laboratory serves as a moat and also depreciates.
In contrast to the consumer healthcare model that opens in Sweden, then expands to London before entering New York, and the high customer spend of functional medicine clinics: Neko follows a standardized scanning plus fixed pricing model rather than personalized long consultations. The industry phase shifts from European validation to the U.S. flagship. Control lies in immediate results; failing to provide on-the-spot explanations will revert to traditional blood tests sent by mail.
Structural changes belong to technological substitution. The mechanism is: once imaging, blood, and body composition can be compiled into an explainable report within an hour, the time tax of specialized hospital appointments is dismantled; pricing shifts from project stacking to package deals. Insurance may not follow suit, and the out-of-pocket market will first seize entry with $499.
ABAB News · Cognitive Law
Preventive healthcare sells a complete hour before becoming ill
Immediate results feel more like a product than just an additional test
The preview post of the flagship store serves as an early price anchor, more effective than advertising